Trial · NCT01077596
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | New Antidepressant Exposure in Colorectal Cancer: Cases | 350 | |
| Overall Study | STARTED | New Antidepressant Exposure in Colorectal Cancer: Controls | 1,050 | |
| Overall Study | STARTED | New Antidepressant Exposure in Lung Cancer: Cases | 457 | |
| Overall Study | STARTED | New Antidepressant Exposure in Lung Cancer: Controls | 1,370 | |
| Overall Study | STARTED | New Antidepressant Exposure in Bladder Cancer: Cases | 294 | |
| Overall Study | STARTED | New Antidepressant Exposure in Bladder Cancer: Controls | 882 | |
| Overall Study | STARTED | Antidepressant Exposure in Uterine Cancer: Cases | 308 | |
| Overall Study | STARTED | New Antidepressant Exposure in Uterine Cancer: Controls | 837 | |
| Overall Study | STARTED | New Antidepressant Exposure in Breast Cancer: Cases | 2,842 | |
| Overall Study | STARTED | New Antidepressant Exposure in Breast Cancer: Controls | 28,420 | |
| Overall Study | STARTED | New Antidepressant Exposure in Prostate Cancer: Cases | 2,215 | |
| Overall Study | STARTED | New Antidepressant Exposure in Prostate Cancer: Controls | 22,150 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Colorectal Cancer: Cases | 350 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Colorectal Cancer: Controls | 1,050 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Lung Cancer: Cases | 457 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Lung Cancer: Controls | 1,370 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Bladder Cancer: Cases | 294 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Bladder Cancer: Controls | 882 | |
| Overall Study | COMPLETED | Antidepressant Exposure in Uterine Cancer: Cases | 308 | |
| Overall Study | COMPLETED | New Antidepressant Exposure in Uterine Cancer: Controls | 837 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01077596/flow